Helen Y Chen(陳以芳), Ph.D.
Secretary
Board Director

Helen Chen currently serves as the vice president of business development of Ambryx Biotechnology, Inc, a leader in anti-obesity therapeutics. Prior to joining Ambryx, Dr. Chen was a project analyst at Beachhead Consulting, a strategic advisor to many of the companies specializing in drug discovery tools development. She was also the co-founder and partner of the Technology Evaluation Group, a consulting firm that specializes in the technology assessment of pharmaceutical compounds and medical devices for venture capitalists and biotech start-up companies. She received her Ph.D. in Biomedical Sciences from the University of California, San Diego, and her B.S. degree from Yale University.